As expected, overexpression of ACSL4 significantly restored the invasive and metastatic capacities of ZEB2 knockdown cells by 35.1% and 32.4%, respectively (Figure 2I, J), indicating that ACSL4 is essential for ZEB2-mediated breast cancer invasion and migration. This evidence concerns the gene ACSL4 and breast cancer.